Healthcare

Our Healthcare Group is a leading provider of financing and strategic advice to large and established enterprises as well as to earlier-stage growth companies in the healthcare sector.

Mizuho's inventive ideas, deep industry knowledge and superior capital markets execution have made our firm a trusted advisor to companies in the Pharmaceutical, Biotech, Medical Devices and Healthcare Services Sectors.

Capital solutions for every stage of growth

In collaboration with Mizuho's product specialists and Financial Sponsors team, we have led high-profile M&A and acquisition-financing deals as well as growth-stage financings. We provide clients a full suite of capabilities, including debt and equity offerings, leveraged finance, risk-focused derivative solutions, strategic advisory, corporate finance and working capital solutions.

Notable Transactions

  • Active Bookrunner on HCA Healthcare’s $5.25 billion senior notes
  • Active Bookrunner on Pfizer’s €3.3 billion senior notes
  • Joint Bookrunner on Vaxcyte’s $1.5 billion follow-on offering
  • Active Bookrunner on BridgeBio’s $575 million convertible senior notes offering
  • Financial Advisor to PRISM Vision Group in its $1.1 billion sale to McKesson Corporation
  • Financial Advisor to Medical Review Institute of America (MRIoA), a portfolio company of Summit Partners, in the strategic investment from Parthenon Capital

Industry expertise

  • Biotech
  • Pharma
  • Medical Devices
  • Healthcare Services
  • Life Sciences Tools & Diagnostics

Latest Insights

Sector Outlook 2026

Sector Outlook 2026

December 19, 2025
Reuters Article: Mizuho’s Katz sees 'fertile' conditions driving robust M&A market into 2026

Reuters Article: Mizuho’s Katz sees 'fertile' conditions driving robust M&A market into 2026

December 4, 2025
Leading Through the Changing Global Order

Leading Through the Changing Global Order

November 17, 2025
back-to-top-blue